Many counties do not have medication for opioid use disorder (MOUD) services available through providers and treatment ...

The 2024 legislative session of the Connecticut General Assembly produced a number of new statutory provisions impacting the operations of ...

Ozempic has been called a "wonder drug," with a growing body of research showing that it may help treat a huge range of ...

A new study linked weight loss drugs known as semaglutides (Ozempic is one) to a lower risk of opioid overdoses. Doctors tell ...

The federal funds will support substance use prevention and treatment efforts, workforce capacity building and access to ...

In the ongoing fight against opioid addiction, Gov. Gavin Newson has signed a bill aimed at expanding access to methadone ...

Medication for opioid use disorder can save lives. But fewer than half of jails surveyed across the country provide it, a new ...

Government in action saves lives, a reader argues, and other letters published Sept. 23-29, 2024, ponder farm histories, futures and policy.

The shortage of popular diabetes and weight-loss drugs known as GLP-1s — and insurers’ uneven coverage of them — is putting an unprecedented supply of compounded drugs in consumers' medicine cabinets.

Conservatives like Pierre Poilievre tout a decline in deaths as proof Alberta's emphasis on recovery works. That's premature ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

Patients with opioid use disorder who receive higher doses of a drug to treat their addiction are more likely to ...